Table 2 Serum periostin (ng/mL) levels at time points during study
Time points | Periostin | |||||
|---|---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Min to max | Difference from baseline mean (SD) | Difference (95% CI) from baseline log periostina | Overall P value <0.001 | |
Asthma | ||||||
0 (0800) | 53.5 (13.6) | 51.7 (41.5–63.7) | 33.9–76.2 | |||
2 (1000) | 52.1 (12.5) | 51.3 (40.8–63.0) | 32–71.4 | −1.4 (2.2) | −0.02 (−0.05 to 0.003) | 0.08 |
4 (1200) | 51.3 (13.7) | 49.3 (39.3–64.8) | 29.9–70.8 | −2.2 (3.3) | −0.05 (−0.07 to −0.02) | <0.001 |
6 (1400) | 51.0 (12.7) | 51.7 (39.4–61.7) | 31.2–69.6 | −2.5 (2.5) | −0.05 (−0.07 to −0.02) | <0.001 |
8 (1600) | 50.6 (12.4) | 52.3 (38.9–60.4) | 32.3–70.0 | −2.9 (3.7) | −0.05 (−0.08 to −0.03) | <0.001 |
10 (1800) | 50.9 (13.4) | 50.3 (38.9–61.2) | 30.3–71.6 | −2.6 (2.6) | −0.05 (−0.08 to −0.03) | <0.001 |
Non-asthma | ||||||
0 (0800) | 50.5 (13.0) | 49.4 (42.5–62.7) | 28.6–70.5 | |||
2 (1000) | 50.3 (13.4) | 48.6 (39.7–61.2) | 28.7–72.7 | −0.2 (2.7) | −0.006 (−0.04 to 0.02) | 0.71 |
4 (1200) | 47.7 (12.2) | 46.3 (39.5–59.7) | 27.7–67.0 | −2.8 (2.5) | −0.06 (−0.09 to −0.03) | <0.001 |
6 (1400) | 46.6 (11.3) | 45.0 (39.8–53.8) | 28.6–65.5 | −3.9 (3.6) | −0.08 (−0.11 to −0.05) | <0.001 |
8 (1600) | 46.5 (11.9) | 43.8 (38.6–55.9) | 27.9–68.2 | −4.0 (2.9) | −0.08 (−0.11 to −0.05) | <0.001 |
10 (1800) | 46.2 (11.5) | 46.6 (37.7–55.0) | 29.2–66.3 | −4.2 (3.2) | −0.08 (−0.11 to −0.06) | <0.001 |